Legal and ComplianceCommercial Arbitration FiledSep 28, 2026 · 4:33pm ET
ALDXAldeyra Therapeutics, Inc.
Aldeyra Therapeutics Announces Intent to Submit Formal Dispute Resolution Request for Reproxalap
The company plans to address the FDA's Complete Response Letter for dry eye disease treatment.
Legal and ComplianceCommercial Arbitration FiledSep 28, 2026 · 4:33pm ET
ALDXAldeyra Therapeutics, Inc.+25.0%
Aldeyra Therapeutics Announces Intent to Submit Formal Dispute Resolution Request for Reproxalap